Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,258,701 papers from all fields of science
Search
Sign In
Create Free Account
YT 146
Known as:
YT-146
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
2-(1-octynyl)adenosine
Broader (2)
Adenosine
Alkynes
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts.
J. Sasamori
,
Yohei Abe
,
T. Marunouchi
,
Y. Manome
,
T. Uchibori
,
K. Tanonaka
Biological and Pharmaceutical Bulletin
2015
Corpus ID: 44350999
This study investigated the effects of an adenosine receptor agonist, 2-octynyladenosine (YT-146), on mitochondrial function in…
Expand
Highly Cited
2000
Highly Cited
2000
Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
N. Harada
,
K. Okajima
,
+4 authors
T. Katsuragi
Journal of Pharmacology and Experimental…
2000
Corpus ID: 44824349
To examine whether adenosine reduces ischemia/reperfusion (I/R)-induced liver injury by inhibiting leukocyte activation via A(2…
Expand
1998
1998
Effects of YT-146 [2-(1-octynyl) adenosine], an adenosine A2A receptor agonist, on cAMP production and noradrenaline release in PC12 cells.
T. Ono
,
I. Matsuoka
,
S. Ohkubo
,
J. Kimura
,
H. Nakanishi
Japanese Journal of Pharmacology
1998
Corpus ID: 22686784
Effects of YT-146 [2-(1-octynyl) adenosine], an adenosine A2 receptor agonist, on cAMP production and noradrenaline (NA) release…
Expand
1995
1995
Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury.
Y. Takiguchi
,
Mitsuyo Nagano
,
Y. Ikeda
,
M. Nakashima
European Journal of Pharmacology
1995
Corpus ID: 46408086
Highly Cited
1994
Highly Cited
1994
Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells.
T. Iwamoto
,
S. Umemura
,
+4 authors
M. Ishii
Biochemical and Biophysical Research…
1994
Corpus ID: 31696480
The involvement of endothelial adenosine A2 receptor-cAMP system in A2 receptor-mediated vasodilation in human aortic endothelial…
Expand
1994
1994
Antihypertensive effects of 2-octynyladenosine (YT-146), a selective adenosine A2 receptor agonist, in Dahl salt-sensitive rats.
T. Iwamoto
,
S. Umemura
,
+4 authors
M. Ishii
American Journal of Hypertension
1994
Corpus ID: 39757914
The antihypertensive effects of a novel adenosine A2 receptor agonist, 2-octynyl adenosine (YT-146), were evaluated in Dahl salt…
Expand
1994
1994
Evidence against KATP channel involvement in adenosine receptor-mediated dilation of epicardial vessels.
S. R. Makujina
,
H. Olanrewaju
,
Syed Jamal Mustafa
American Journal of Physiology
1994
Corpus ID: 25865478
The purpose of this study was to determine whether ATP-glyburide-sensitive K+ (KATP-glyburide) channels are involved in the…
Expand
1993
1993
Opening of ATP-sensitive K+ channels responsible for adenosine A2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein.
S. Furukawa
,
K. Satoh
,
N. Taira
European Journal of Pharmacology
1993
Corpus ID: 195081
1992
1992
Vasodepressor mechanisms of 2-(1-octynyl)-adenosine (YT-146), a selective adenosine A2 receptor agonist, involve the opening of glibenclamide-sensitive K+ channels.
F. Yoneyama
,
H. Yamada
,
K. Satoh
,
N. Taira
European Journal of Pharmacology
1992
Corpus ID: 36211981
1991
1991
Pharmacological profile of the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146) in the cardiovascular system.
K. Kogi
,
T. Uchibori
,
K. Aihara
,
T. Yamaguchi
,
T. Abiru
Japanese Journal of Pharmacology
1991
Corpus ID: 22365080
We investigated the cardiovascular effects of 2-octynyladenosine (YT-146), an adenosine A2 agonist, in various mammalian…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE